Patent ID: 8236817

Claim:
Crystalline moxifloxacin hydrochloride hydrated form A, characterized by an X-ray diffraction spectrum having the following principal peaks: ReI. Intens. Angle (2 θ) D (A) (I/I 0 ) 5.815 15.1858 49.8 7.22 12.2335 100 8.575 10.3032 86.1 10.335 8.5522 87.2 12.31 7.1842 19.4 13.2 6.7018 17 14.085 6.2826 16.3 14.535 6.0891 11.1 14.87 5.9527 20.6 15.185 5.8299 17.6 15.675 5.6487 1.9 16.62 5.3296 18.3 17.335 5.1114 60.1 17.85 4.965 80.9 19.315 4.5916 53.7 19.76 4.4892 19.1 20.375 4.3551 2.5 21.64 4.1033 47.6 22.295 3.9842 12.7 23.16 3.8373 4.2 23.625 3.7628 1.9 24.705 3.6007 26.9 25.115 3.5428 17.6 25.815 3.4483 15.6 26.44 3.3682 39.4 27.365 3.2564 36.3 27.97 3.1874 17.8 28.36 3.1444 14.5 29.015 3.0749 28.2 29.965 2.9795 13.9 30.545 2.9243 4.8 31.575 2.8312 5.9 32.27 2.7718 12.2 33.9 2.6421 6.4.